Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study.

MLA

Kaiser, Francesca, et al. “Ponatinib Alone or with Chemo-Immunotherapy in Heavily Pre Treated Philadelphia-like Acute Lymphoblastic Leukemia: A CAMPUS ALL Real-Life Study.” Haematologica, vol. 109, no. 12, Dec. 2024, pp. 4095–99. EBSCOhost, https://doi.org/10.3324/haematol.2024.285258.

APA

Kaiser, F., Lunghi, M., Cardinali, D., Bellomarino, V., Beldinanzi, M., Starza, I. D., Malfona, F., Basilico, C. M., Defina, M., Mastaglio, S., Giglio, F., Lazzarotto, D., Salutari, P., Piccini, M., Cardinali, V., Pierini, A., Fracchiolla, N. S., Di Biase, F., Annunziata, M., … Chiaretti, S. (2024). Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study. Haematologica, 109(12), 4095–4099. https://doi.org/10.3324/haematol.2024.285258

Chicago

Kaiser, Francesca, Monia Lunghi, Deborah Cardinali, Vittorio Bellomarino, Marco Beldinanzi, Irene Della Starza, Francesco Malfona, et al. 2024. “Ponatinib Alone or with Chemo-Immunotherapy in Heavily Pre Treated Philadelphia-like Acute Lymphoblastic Leukemia: A CAMPUS ALL Real-Life Study.” Haematologica 109 (12): 4095–99. doi:10.3324/haematol.2024.285258.